Drugs / ProSavin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01856439 | May 2011 → Nov 2021 | Parkinson disease | Axovant Sciences Ltd. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ProSavin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01856439 ↗ |
| Action | Restore | “aimed at restoring local and continuous dopamine production” PMID 24412048 ↗ Jan 2014 |
| Route | Other | “bilateral injection into the putamen” PMID 24412048 ↗ Jan 2014 |